Search results
O28.5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Abn chromsoml and genetic find on antenat screen of mother. The 2025 edition of ICD-10-CM O28.5 became effective on October 1, 2024.
Genetic screening for chromosomopathy is performed in the first trimester of pregnancy by determining fetal nuchal translucency (NT), and the pregnancy associated plasma protein-A (PAPP-A) and free human chorionic gonadotropin (free-beta HCG) biomarkers in maternal serum. Methods.
O28.5 is a billable diagnosis code used to specify a medical diagnosis of abnormal chromosomal and genetic finding on antenatal screening of mother. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025.
A type 1 excludes note indicates that the code excluded should never be used at the same time as O28. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
30 lis 2015 · Mothers with pregnancies identified as high risk for Down's syndrome by serum testing are often offered immediate definitive testing by amniocentesis, whereas those considered low risk are assessed for Down's syndrome by inspection at birth.
1 lip 2024 · Evaluation of cell-free DNA (cfDNA) in maternal blood is now the most common method for screening for Down syndrome, and this test also screens for trisomy 18 (Edwards syndrome, the second most common autosomal trisomy among live births) and trisomy 13 (Patau syndrome).
8 mar 2018 · Blood test. This blood test measures the levels of pregnancy-associated plasma protein-A (PAPP-A) and the pregnancy hormone known as human chorionic gonadotropin (HCG). Abnormal levels of PAPP-A and HCG may indicate a problem with the baby. Nuchal translucency test.
